{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:09:01Z","timestamp":1793329741005,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.ctrv.2010.02.002","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T10:16:08Z","timestamp":1267611368000},"page":"451-457","source":"Crossref","is-referenced-by-count":132,"title":["Male breast cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"C\u00e9sar","family":"G\u00f3mez-Raposo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Zambrana T\u00e9var","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sereno Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"L\u00f3pez G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ctrv.2010.02.002_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","article-title":"Male breast cancer","volume":"367","author":"Fentiman","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2010.02.002_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ctrv.2010.02.002_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","article-title":"Epidemiology of breast cancer","volume":"14","author":"Weiss","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ctrv.2010.02.002_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men: a population-based study","volume":"101","author":"Giordano","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib5","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/djn329","article-title":"Prospective evaluation of risk factors for male breast cancer","volume":"100","author":"Brinton","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2010.02.002_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910530403","article-title":"Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors","volume":"53","author":"Sasco","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.aje.a116360","article-title":"Breast cancer in men: risk factors with hormonal implications","volume":"135","author":"Thomas","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.ctrv.2010.02.002_bib8","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.10449","article-title":"Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews","volume":"94","author":"Brenner","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib9","first-page":"59","article-title":"Increased plasma prolactin levels in a group of men with breast cancer \u2013 a preliminary study","volume":"10","author":"Olsson","year":"1990","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jama.1951.03670010011002","article-title":"Bilateral carcinoma of male breast after estrogen therapy","volume":"146","author":"McClure","year":"1951","journal-title":"JAMA"},{"key":"10.1016\/j.ctrv.2010.02.002_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.2.5597.83","article-title":"Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics","volume":"2","author":"Symmers","year":"1968","journal-title":"Brit Med J"},{"key":"10.1016\/j.ctrv.2010.02.002_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/030089169007600106","article-title":"Hormones in male breast cancer","volume":"76","author":"Ballerini","year":"1990","journal-title":"Tumori"},{"key":"10.1016\/j.ctrv.2010.02.002_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jmg.8.4.460","article-title":"Carcinoma of the breast and Klinefelter\u2019s syndrome","volume":"8","author":"Harnden","year":"1971","journal-title":"J Med Genet"},{"key":"10.1016\/j.ctrv.2010.02.002_bib14","first-page":"4293","article-title":"Prevalence of Klinefelter\u2019s syndrome in male breast cancer patients","volume":"17","author":"Hultborn","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnci\/83.12.849","article-title":"Breast cancer in men: aspects of familial aggregation","volume":"83","author":"Rosenblatt","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2010.02.002_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-137-8-200210150-00013","article-title":"Breast cancer in men","volume":"137","author":"Giordano","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctrv.2010.02.002_bib17","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/jnci\/92.14.1126","article-title":"Genetic and hormonal risk factors in breast cancer","volume":"92","author":"Martin","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2010.02.002_bib18","first-page":"342","article-title":"BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy","volume":"63","author":"Ottini","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib20","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.2006.06.9443","article-title":"Screening for a BRCA2 rearrangement in high-risk breast\/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes","volume":"25","author":"Machado","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2010.02.002_bib22","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr419","article-title":"BRCA1 and BRCA2 mutations in a population-based study of male breast cancer","volume":"4","author":"Basham","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib23","first-page":"313","article-title":"Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population","volume":"60","author":"Friedman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ctrv.2010.02.002_bib24","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bjc.1997.574","article-title":"Germline BRCA2 mutations in men with breast cancer","volume":"76","author":"Mavraki","year":"1997","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib25","first-page":"1367","article-title":"BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease","volume":"58","author":"Haraldsson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","article-title":"BRCA2 germline mutations in male breast cancer cases and breast cancer families","volume":"13","author":"Couch","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.ctrv.2010.02.002_bib27","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population","volume":"60","author":"Thorlacius","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ctrv.2010.02.002_bib28","first-page":"995","article-title":"High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history","volume":"59","author":"Csokay","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1008339009528","article-title":"BRCA2 germ-line mutations in Spanish male breast cancer patients","volume":"11","author":"Diez","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/10906570050501579","article-title":"Genetic analyses of male breast cancer in Israel","volume":"4","author":"Sverdlov","year":"2000","journal-title":"Genet Test"},{"key":"10.1016\/j.ctrv.2010.02.002_bib31","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib32","first-page":"4452","article-title":"BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients","volume":"9","author":"Kwiatkowska","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib33","unstructured":"National Comprehensive Cancer Network (NCCN). Guidelines available online at www.nccn.org."},{"key":"10.1016\/j.ctrv.2010.02.002_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jmg.38.3.159","article-title":"Male breast cancer in Cowden syndrome patients with germline PTEN mutations","volume":"38","author":"Fackenthal","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.ctrv.2010.02.002_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1006030116357","article-title":"Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome","volume":"53","author":"Boyd","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2010.02.002_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.10-7-471","article-title":"A review of the diagnosis and management of male breast cancer","volume":"10","author":"Giordano","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2010.02.002_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1572-0241.1998.00231.x","article-title":"Risk of breast cancer in men with liver cirrhosis","volume":"93","author":"Sorensen","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1023\/A:1011216502678","article-title":"Breast cancer risk in male alcoholics in Sweden","volume":"12","author":"Weiderpass","year":"2001","journal-title":"Cancer Cause Control"},{"key":"10.1016\/j.ctrv.2010.02.002_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1008869003012","article-title":"Risk factors for male breast cancer (United States)","volume":"9","author":"Hsing","year":"1998","journal-title":"Cancer Cause Control"},{"key":"10.1016\/j.ctrv.2010.02.002_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0002-9610(00)00571-7","article-title":"The diagnostic accuracy of mammography in the evaluation of male breast disease","volume":"181","author":"Evans","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctrv.2010.02.002_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiographics.19.3.g99ma01559","article-title":"Mammographic appearances of male breast disease","volume":"19","author":"Appelbaum","year":"1999","journal-title":"Radiographics"},{"key":"10.1016\/j.ctrv.2010.02.002_bib42","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","article-title":"Revision of the American Joint Committee on Cancer staging system for breast cancer","volume":"20","author":"Singletary","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/1097-0142(197310)32:4<985::AID-CNCR2820320433>3.0.CO;2-0","article-title":"Male breast cancer. 1: histologic typing and grading of 187 Danish cases","volume":"32","author":"Visfeldt","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00053155","article-title":"Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men","volume":"4","author":"Stalsberg","year":"1993","journal-title":"Cancer Cause Control"},{"key":"10.1016\/j.ctrv.2010.02.002_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ajcp\/111.1.59","article-title":"Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma","volume":"111","author":"Wick","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib46","first-page":"2335","article-title":"Male breast cancer: pathological and immunohistochemical features","volume":"17","author":"Willsher","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib47","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<1947::AID-CNCR10>3.0.CO;2-J","article-title":"Molecular markers in male breast carcinoma","volume":"83","author":"Rayson","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bjc.6690153","article-title":"Androgen receptor expression in male breast carcinoma: lack of clinicopathological association","volume":"79","author":"Pich","year":"1999","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib49","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/bcr733","article-title":"Expression of androgen receptor and prostate-specific antigen in male breast carcinoma","volume":"6","author":"Kidwai","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9610(01)00733-4","article-title":"Status of HER-2 in male and female breast carcinoma","volume":"182","author":"Bloom","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctrv.2010.02.002_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5858\/2003-127-36-MVFB","article-title":"Male versus female breast cancers. A population-based comparative immunohistochemical analysis","volume":"127","author":"Muir","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ctrv.2010.02.002_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/B:BREA.0000019953.92921.7e","article-title":"Her-2\/neu gene amplification and protein expression in primary male breast cancer","volume":"84","author":"Rudlowski","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2010.02.002_bib53","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.02.002_bib54","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.02.002_bib55","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.02.002_bib56","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr2258","article-title":"Immunohistochemical characterization of subtypes of male breast carcinoma","volume":"11","author":"Ge","year":"2009","journal-title":"Brit Cancer Res"},{"key":"10.1016\/j.ctrv.2010.02.002_bib57","first-page":"373","article-title":"Prognostic factors of carcinoma of the male breast","volume":"159","author":"Ouriel","year":"1984","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.ctrv.2010.02.002_bib58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0960-7404(93)90063-5","article-title":"A 50-year experience of male breast cancer: is outcome changing?","volume":"2","author":"Gough","year":"1993","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib59","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/0959-8049(95)00366-5","article-title":"Male breast cancer: results of the treatments and prognostic factors in 397 cases","volume":"31A","author":"Cutuli","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00000658-198308000-00016","article-title":"A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients","volume":"198","author":"Maddox","year":"1983","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2010.02.002_bib61","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0748-7983(98)93608-3","article-title":"Male breast cancer: a 22-year experience","volume":"24","author":"Yildirim","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1021173902253","article-title":"Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy","volume":"77","author":"Albo","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2010.02.002_bib63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jso.20045","article-title":"Efficacy of sentinel lymph node biopsy in male breast cancer","volume":"86","author":"Cimmino","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib64","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejso.2004.02.006","article-title":"Sentinel lymph node biopsy in male breast cancer patients","volume":"30","author":"Goyal","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0142(20010115)91:2<319::AID-CNCR1004>3.0.CO;2-D","article-title":"Sentinel lymph node biopsy in patients with male breast carcinoma","volume":"91","author":"Port","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00006231-200402000-00008","article-title":"Sentinel node biopsy in male breast cancer","volume":"25","author":"De Cicco","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ctrv.2010.02.002_bib67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1634\/theoncologist.12-5-512","article-title":"Sentinel lymph node biopsy in male patients with early breast cancer","volume":"12","author":"Gentilini","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2010.02.002_bib68","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jamcollsurg.2006.06.014","article-title":"Comparative analysis of sentinel lymph node operation in male and female breast cancer patients","volume":"203","author":"Boughey","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ctrv.2010.02.002_bib69","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib70","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<498::AID-CNCR19>3.0.CO;2-R","article-title":"Carcinoma of the breast in males: a multiinstitutional survey","volume":"83","author":"Donegan","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib71","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/1097-0142(19850201)55:3<648::AID-CNCR2820550329>3.0.CO;2-3","article-title":"Long-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases","volume":"55","author":"Spence","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib72","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1200\/JCO.1984.2.8.903","article-title":"Male breast cancer: a 13-year review of 89 patients","volume":"2","author":"Erlichman","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib73","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00000421-199608000-00002","article-title":"Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience","volume":"19","author":"Schuchart","year":"1996","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0039-6060(99)70135-2","article-title":"An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients","volume":"126","author":"Scott-Conner","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.ctrv.2010.02.002_bib75","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V","article-title":"Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955\u20131996","volume":"85","author":"Goss","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0960-9776(96)90058-2","article-title":"A review of the management of the male breast carcinoma based on an analysis of 420 treated cases","volume":"5","author":"Ribeiro","year":"1996","journal-title":"Breast"},{"key":"10.1016\/j.ctrv.2010.02.002_bib77","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.1992.50","article-title":"Adjuvant tamoxifen for male breast cancer (MBC)","volume":"65","author":"Ribeiro","year":"1992","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib78","first-page":"S42","article-title":"Male breast cancer: the M.D. Anderson experience with adjuvant therapy","volume":"82","author":"Giordano","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2010.02.002_bib79","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-#","article-title":"Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients","volume":"74","author":"Anelli","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib80","doi-asserted-by":"crossref","unstructured":"Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Lancet 1987;2:171\u20135.","DOI":"10.1016\/S0140-6736(87)90762-8"},{"key":"10.1016\/j.ctrv.2010.02.002_bib81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00000421-200206000-00006","article-title":"Efficacy of anastrozole in male breast cancer","volume":"25","author":"Giordano","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib82","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jso.20233","article-title":"Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer","volume":"90","author":"Zabolotny","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib83","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1210\/jc.85.7.2370","article-title":"Estrogen suppression in males: metabolic effects","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ctrv.2010.02.002_bib84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00000421-198702000-00013","article-title":"Adjuvant chemotherapy in males with cancer of the breast","volume":"10","author":"Bagley","year":"1987","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib85","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/1097-0142(19891015)64:8<1583::AID-CNCR2820640804>3.0.CO;2-Q","article-title":"Role of adjuvant chemotherapy in male breast cancer","volume":"64","author":"Patel","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib86","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/02841869409083946","article-title":"Male breast cancer. Report of a series of 50 cases","volume":"33","author":"Izquierdo","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib87","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/cncr.21526","article-title":"Adjuvant systemic therapy for male breast carcinoma","volume":"104","author":"Giordano","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib88","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1126\/science.95.2478.654","article-title":"Effect of orchiectomy on skeletal metastases from cancer of the male breast","volume":"95","author":"Farrow","year":"1942","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2010.02.002_bib89","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-117-9-771","article-title":"Carcinoma of the male breast","volume":"117","author":"Jaiyesimi","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctrv.2010.02.002_bib90","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000226061","article-title":"Hormonal treatment of disseminated male breast cancer","volume":"42","author":"Lopez","year":"1985","journal-title":"Oncology"},{"key":"10.1016\/j.ctrv.2010.02.002_bib91","first-page":"275","article-title":"Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report","volume":"13","author":"Labrie","year":"1990","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.ctrv.2010.02.002_bib92","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/1097-0142(19930715)72:2<502::AID-CNCR2820720228>3.0.CO;2-1","article-title":"Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer","volume":"72","author":"Lopez","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib93","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1097-0142(19880801)62:3<474::AID-CNCR2820620305>3.0.CO;2-2","article-title":"Advanced male breast cancer treatment with the LH\u2013RH analogue buserelin alone or in combination with the antiandrogen flutamide","volume":"62","author":"Doberauer","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.revmed.2003.12.006","article-title":"Complete remission obtained with letrozole in a man with metastatic breast cancer","volume":"25","author":"Italiano","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ctrv.2010.02.002_bib95","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-006-9266-0","article-title":"Fulvestrant in advanced males breast cancer","volume":"101","author":"Agrawal","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2010.02.002_bib96","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.243.17.1739","article-title":"Chemotherapy for advanced male breast cancer","volume":"243","author":"Yap","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.ctrv.2010.02.002_bib97","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1097-0142(19930101)71:1<154::AID-CNCR2820710125>3.0.CO;2-#","article-title":"The prognosis of breast cancer in males. A report of 335 cases","volume":"71","author":"Guinee","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/B:BREA.0000010701.08825.2d","article-title":"Is male breast cancer similar or different than female breast cancer?","volume":"83","author":"Anderson","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2010.02.002_bib99","first-page":"191","article-title":"Male breast cancer. Does the prognosis differ compared to female?","volume":"47","author":"Herman","year":"2000","journal-title":"Neoplasma"},{"key":"10.1016\/j.ctrv.2010.02.002_bib100","first-page":"185","article-title":"Carcinoma of the male breast: analysis of prognosis compared with matched female patients","volume":"173","author":"Borgen","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib101","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-9610(97)89592-X","article-title":"A comparison outcome of male breast cancer with females breast cancer","volume":"173","author":"Willsher","year":"1997","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctrv.2010.02.002_bib102","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1200\/JCO.2006.09.1710","article-title":"Racial disparities in treatment and survival of male breast cancer","volume":"25","author":"Crew","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib103","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/0959-8049(96)00154-2","article-title":"Comparison of prognostic markers detected by immunochemistry in male and female breast carcinomas","volume":"32A","author":"Weber-Chappuis","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.002_bib104","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.2000.18.16.2948","article-title":"Oncogenes and male breast carcinoma: c-erbB2 and p53 coexpression predicts poor survival","volume":"18","author":"Pich","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.MP.0000022251.61944.1D","article-title":"Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu and p53 with treatment and survival. A study of 65 cases","volume":"15","author":"Wang-Rodr\u00edguez","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib106","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1002\/1096-9098(200012)75:4<252::AID-JSO5>3.0.CO;2-2","article-title":"Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer","volume":"75","author":"Shpitz","year":"2000","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2010.02.002_bib107","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","article-title":"Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients","volume":"94","author":"Look","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2010.02.002_bib108","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1012221921416","article-title":"Clinical relevance or biologic factors in male breast cancer","volume":"68","author":"Meijer-van Gelder","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2010.02.002_bib109","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jnci\/94.17.1330","article-title":"Risk of subsequent cancer following breast cancer in men","volume":"94","author":"Auvinen","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2010.02.002_bib110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1010639429207","article-title":"Second primary breast cancer in men","volume":"66","author":"Dong","year":"2001","journal-title":"Breast Cancer Res Treat"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737210000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737210000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T18:25:48Z","timestamp":1685471148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737210000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0305737210000228"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2010.02.002","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}